Page last updated: 2024-08-25

zoledronic acid and Acute Kidney Injury

zoledronic acid has been researched along with Acute Kidney Injury in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's6 (40.00)24.3611
2020's4 (26.67)2.80

Authors

AuthorsStudies
Eastell, R; Khwaja, A; Peel, N; Salam, S; Schini, M; Thomas, E; Toronjo-Urquiza, L; Walsh, JS1
Gupta, S; Mount, DB; Nigwekar, SU; Portales-Castillo, I; Rennke, HG; Yu, EW1
Fixen, CW; Fixen, DR1
Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE1
Cipriani, C; Clementelli, C; Colangelo, L; Fassino, V; Manai, R; Minisola, S; Nieddu, L; Pepe, J1
Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A1
Ashcroft, AJ; Bell, SE; Boyd, KD; Byrne, J; Child, JA; Cook, G; Davies, FE; Drayson, MT; Feyler, S; Gregory, WM; Jackson, GH; Morgan, GJ; Navarro Coy, N; Osborne, WL; Owen, RG; Roddie, H; Ross, FM; Rudin, C; Szubert, AJ; Wu, P1
Joensuu, TK1
Ando, R; Fukami, K; Hashiguchi, M; Hazama, T; Koike, K; Morishige, S; Nagano, M; Nishida, H; Okuda, S; Taguchi, K; Tamaki, K; Ueda, S; Yoshimura, J1
Dowell, JE; Jean, GW; Keisner, SV; Shah, SR; Ussery, SM1
Fukami, K; Koike, K; Morishige, S; Okamura, T; Okuda, S; Taguchi, K; Yakushiji, K1
Hirschberg, R1
Cull, G; Henley, D; Kaye, J; Walsh, J1
Peña, JM; Pernaute, R; Vicente, C; Vives, P1
Bodmer, M; Kummer, O; Ramazzina, C; Rätz Bravo, AE; Zysset Aschmann, Y1

Reviews

2 review(s) available for zoledronic acid and Acute Kidney Injury

ArticleYear
Renal complications from bisphosphonate treatment.
    Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:3

    Topics: Acute Kidney Injury; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Kidney; Kidney Diseases; Nephrotic Syndrome; Pamidronate; Risk Factors; Zoledronic Acid

2012
[Zoledronate-associated end stage renal failure and hypocalcaemia].
    Praxis, 2007, Apr-25, Volume: 96, Issue:17

    Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Biopsy; Bone Density Conservation Agents; Calcium; Creatinine; Diphosphonates; Disease Progression; Female; Follow-Up Studies; Humans; Hypocalcemia; Imidazoles; Kidney Failure, Chronic; Kidney Tubules; Middle Aged; Multiple Myeloma; Pamidronate; Renal Dialysis; Risk Factors; Switzerland; Time Factors; Vitamin D; Zoledronic Acid

2007

Trials

1 trial(s) available for zoledronic acid and Acute Kidney Injury

ArticleYear
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
    British journal of haematology, 2014, Volume: 166, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Drug Administration Schedule; England; Female; Follow-Up Studies; Humans; Imidazoles; Incidence; Male; Middle Aged; Multiple Myeloma; Osteolysis; Zoledronic Acid

2014

Other Studies

12 other study(ies) available for zoledronic acid and Acute Kidney Injury

ArticleYear
Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2022, Volume: 33, Issue:3

    Topics: Acute Kidney Injury; Creatinine; Glomerular Filtration Rate; Humans; Osteoporosis; Zoledronic Acid

2022
Zoledronic Acid-Associated Fanconi Syndrome in Patients With Cancer.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022, Volume: 80, Issue:4

    Topics: Acute Kidney Injury; Amino Acids; Bicarbonates; Bone Density Conservation Agents; Fanconi Syndrome; Humans; Neoplasms; Zoledronic Acid

2022
Renal safety of zoledronic acid for osteoporosis in adults 75 years and older.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2022, Volume: 33, Issue:11

    Topics: Acute Kidney Injury; Aged; Creatinine; Cross-Sectional Studies; Glomerular Filtration Rate; Humans; Kidney; Osteoporosis; Retrospective Studies; Zoledronic Acid

2022
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
    Drug safety, 2022, Volume: 45, Issue:11

    Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid

2022
Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: a pilot study.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:10

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Bone Density Conservation Agents; Calcium; Chemokine CCL2; Diphosphonates; Female; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Imidazoles; Infusions, Intravenous; Interleukin-18; Male; Osteoporosis; Pilot Projects; Renal Elimination; Zoledronic Acid

2017
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:9

    Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid

2013
Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
    Urologia internationalis, 2008, Volume: 80, Issue:4

    Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Creatinine; Diphosphonates; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Male; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Retreatment; Risk Assessment; Treatment Outcome; Zoledronic Acid

2008
[Case of acute kidney injury related to intravenous zoledronic acid in a patient with multiple myeloma].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:5

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Diseases; Dexamethasone; Diphosphonates; Doxorubicin; Humans; Imidazoles; Injections, Intravenous; Male; Multiple Myeloma; Renal Dialysis; Treatment Outcome; Vincristine; Zoledronic Acid

2009
Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Incidence; Male; Middle Aged; Neoplasms; Retrospective Studies; Time Factors; Zoledronic Acid

2012
[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2011, Jan-10, Volume: 100, Issue:1

    Topics: Acute Kidney Injury; Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Injections, Intravenous; Male; Multiple Myeloma; Pyrazines; Zoledronic Acid

2011
Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
    Internal medicine journal, 2005, Volume: 35, Issue:12

    Topics: Acute Kidney Injury; Aged; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Diphosphonates; Fatal Outcome; Female; Humans; Hypocalcemia; Imidazoles; Injections, Intravenous; Magnesium Deficiency; Male; Middle Aged; Multiple Myeloma; Pamidronate; Zoledronic Acid

2005
[Acute kidney failure caused by zoledronic acid (Zometa)].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006, Volume: 26, Issue:4

    Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Diphosphonates; Female; Humans; Imidazoles; Zoledronic Acid

2006